Cancer diagnostics using biomarkers
US11035005B2 · kind B2 · utility
2Cited by
118References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 16, 2013 |
| Grant date | Jun 15, 2021 |
| Priority date | — |
| Expiry date | Jul 23, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed herein, in certain instances, are methods, systems and kits for the diagnosis, prognosis and determination of cancer progression of a cancer in a subject. Further disclosed herein, in certain instances, are methods, systems and kits for determining the treatment modality of a cancer in a subject. The methods, systems and kits comprise expression-based analysis of biomarkers. Further disclosed herein, in certain instances, are probe sets for use in assessing a cancer status in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.